Source: Annual Congress 2005 - The many faces of sarcoidosis II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Vizel, G. R. Nasretdinova, E. A. Vizel (Kazan, Russian Federation). The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease. Eur Respir J 2005; 26: Suppl. 49, 2173

Member's Comments

No comment yet.

Related content which might interest you: The features of patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 436s Year: 2002 Monitoring disease progression in patients with biopsy proven cases of sarcoidosis: A survey Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 The features of sarcoidosis in owerweight patients. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004 The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Incidence of coeliac disease in patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001 The clinical symptoms of newly diagnosed sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Variants of the clinical course of familial pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Does large airway intervention for patients with malignant disease result in early clinical benefit Source: Eur Respir J 2007; 30: Suppl. 51, 434s Year: 2007 Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Does large airway intervention for patients with malignant disease result in early clinical benefit? Source: Annual Congress 2008 - Hot and cold techniques Year: 2008 Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Sinonasal involvement is a severe manifestation of sarcoidosis: a case-control study of 20 patients Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002 Eosinophilic lung disease: clinical features of 25 patients Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006 Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006